Other well-characterized and more frequently mutated genes (e.g., BRAF, RAS, NF1, TP53, PTEN, CDKN2A) were not prognostic in MM, perhaps because such mutations are already found in nevi and primary melanomas (1). This evidence concerns the gene CDKN2A and Miyoshi myopathy.